AccuVein, LLC announced today that the United States Patent and Trademark Office has granted the company a patent for its vascular illumination technology and that a second patent has been allowed.
“With more than a dozen additional patents pending in the United States and around the world we’re very pleased with this news.” said Ron Goldman, President and CEO of AccuVein. “Our technology team has built a stellar portfolio of intellectual property that enables us to deliver the only hand-held vein illumination system in the market.”
Called “miles ahead” by Frost & Sullivan, the AccuVein AV300 is now in use in over 575 hospitals in the United States alone. This makes it the most widely deployed vein illumination system in the world. It helps healthcare professionals locate veins for blood draw, IV infusion and blood donation by projecting a pattern of light on patient’s skin that reveals the position of underlying veins. This 10-ounce, hand-held device is available with a range of hands-free options so that it can quickly free the practitioner’s hands to perform the venipuncture.
“We’re extremely gratified that the USPTO has recognized the significant intellectual property position that we have developed for vein illumination.” said Joe Zott, Vice President of Operations and Engineering for AccuVein. “We continue to build value for our customers through innovation. Industry recognition such as our gold-level Medical Design Excellence Award and Frost & Sullivan’s Product of the Year award attest to this.”
About AccuVein, LLC
AccuVein, LLC (accuvein.com) is a supplier of innovative, cutting-edge medical devices. The AV300 is a breakthrough product, allowing health care providers to see a map of the position of peripheral veins on the skin’s surface with the goal of helping to improve venipuncture procedures. Built using AccuVein’s expertise in medical device miniaturization and user-intuitive design, the AV300 is the world’s first portable, non-contact vein illumination solution. AccuVein has filed applications for more than a dozen patents on the AV300’s technology. It is in use at more than 575 U.S. hospitals and available for sale in 60 countries.